The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

BACKGROUND: BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, there is a paucity of reference data pertaining to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitani, Seiichiro, Taniguchi, Hiroya, Sugiyama, Keiji, Masuishi, Toshiki, Honda, Kazunori, Narita, Yukiya, Kadowaki, Shigenori, Ura, Takashi, Ando, Masashi, Tajika, Masahiro, Yatabe, Yasushi, Muro, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348546/
https://www.ncbi.nlm.nih.gov/pubmed/30719102
http://dx.doi.org/10.1177/1758835918820298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348546/
https://www.ncbi.nlm.nih.gov/pubmed/30719102
http://dx.doi.org/10.1177/1758835918820298

Ejemplares similares